Union Budget 2024: Mixed reactions from healthcare and medical industry experts
From praise for cancer treatment cost cuts to calls for more R&D incentives, reactions reflect diverse views on fiscal health policies. ( Excerpts from their statements) Jyotsna Govil, Chairperson of the Indian Cancer Society: “Our Finance Minister Nirmala Sitharaman has relieved the cancer patients by announcing the cancer treatment medicines. The exemption of customs duty […]
Read More
Budget provides customs duty exemptions for three cancer treatment drugs
Finance Minister proposes changes in the basic customs duty on X-ray tubes and flat panel detectors’ provides ₹2,143 crore as production linked incentives for the pharmaceutical industry The Union government has continued its emphasis on tackling non-communicable diseases, and allocating funds for research in the healthcare sector, with Finance Minister Nirmala Sitharaman on July 23 […]
Read More
Union budget 2024: Family welfare schemes get a major boost
Allocation for family welfare schemes saw a 35% increase Even as the overall increase in budget allocation in health sector is marginal, family welfare schemes have seen a rise of a whopping 35 per cent indicating the community approach taken by the government. Mission Indradhanush, India’s Universal Immunization Programme, Janani Shishu Suraksha Karyakram (JSSK) that […]
Read More
Limited mention of healthcare sector in Union Budget 2024; Longstanding demands go unaddressed: Experts
The health sector was expecting the health budget to be increased to 2.5 per cent of GDP, promotion of medical value tourism and reduction in taxation which were not mentioned in the budget presented by the FM. However the industry welcomed the move of exemption of three cancer drugs from customs duty and the BCD […]
Read More
Union Budget: Lower custom duty on import of medical devices, say experts
New Delhi, July 18 (IANS) Ahead of the upcoming Union Budget 2024-25, experts on Thursday called on lowering customs duty on import of global medical devices.Finance Minister Nirmala Sitharaman is expected to present the Union Budget 2024 on July 23. Speaking to IANS, Pavan Choudary, Chairman, of the Medical Technology Association of India (MTaI) said, […]
Read More
Government eases rules for global sourcing of medical gear
Allows global tenders for procurement of 354 medical deveices amid concerns over lack of domestic options The government has allowed global tenders to be floated for procurement of 354 medical devices after the health ministry raised concerns over the lack of domestic options, a move that could ease access to state-of-the-art medical devices which are […]
Read More
Navigating the Complexities of Medical Device Pricing: Insights from Pavan Choudary
In an exclusive interview with Arunima Rajan, Pavan Choudary, Chairman of the Medical Technology Association of India (MTaI), discusses the pricing framework for medical devices, shedding light on its critical aspects and implications for the industry. What are the key considerations or factors that the NPPA should take into account while developing the new pricing […]
Read More
Can price control create treatment Bias?
The article explores the complex repercussions of price controls in healthcare and the emerging evidence of unintended consequences. Levitt and Dubner in their book Freakonomics quote a medical study which found that obstetricians in areas with declining birth rates are much more likely to perform cesarean section deliveries than obstetricians in growing areas – suggesting […]
Read More
Medical device bodies welcome CDSCO order on self-reporting adverse effects
Medical device associations have flagged the need to ensure systematic reviews while welcoming the Central Drugs Standard Control Organisation’s (CDSCO) move to urge all licensed medical device manufacturers to use the Materiovigilance Programme of India (MvPI) portal to self-report adverse events related to the devices. In a circular dated May 15, the drug regulator stated […]
Read More